Skip to main content
Atrás
Watch Compare

PAVmed Inc.

Calidad de datos: 100%
PAVM
Nasdaq Manufacturing Measuring & Analyzing Instruments
$9.24
▼ $0.51 (-5.18%)
Cap. Mercado: 61.54 M
Precio
$9.75
Cap. Mercado
61.54 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Revenue declined -38.61% annually over 5 years
Earnings declined -98.99% over the past year
ROE of 1.14% is below average
Net margin of 564.79% shows strong profitability
Negative free cash flow of -5.24 M
P/E of 153.47 — premium valuation

Crecimiento

Revenue Growth (5Y)
-38.61%
Below sector avg (1.82%)
Revenue (1Y)-97.63%
Earnings (1Y)-98.99%
FCF Growth (3Y)N/A

Calidad

Return on Equity
1.14%
Above sector avg (-53.34%)
ROIC-56.48%
Net Margin564.79%
Op. Margin-30712.68%

Seguridad

Debt / Equity
N/A
Current Ratio0.40
Interest Coverage-1038.38

Valoración

PE (TTM)
153.47
Above sector avg (-1.47)
P/B Ratio1.89
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E 153.5 -1.5
P/B 1.9 1.6
ROE % 1.1 -53.3
Net Margin % 564.8 -41.5
Rev Growth 5Y % -38.6 1.8
D/E — 0.3

Precio Objetivo de Analistas

2 analistas
Strong Buy
Actual
$9.24
+2746.3%
Objetivo
$263.00
$16.00
$263.00
$510.00
Pronóstico
EPS Futuro -$1.75
Ingresos Est. 805,000.0

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2027 -$1.75
-$1.75 – -$1.75
 805,000.0 1
FY2026 -$17.10
-$17.10 – -$17.10
 480,000.0 1

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$4.50 -$1.05 +76.7%
Q32025 -$6.00 -$0.60 +90.0%
Q22025 -$7.50 -$1.50 +80.0%
Q12025 -$8.70 -$2.10 +75.9%

All Fundamental Metrics
Growth
Revenue Growth (1Y) -97.63% Revenue Growth (3Y) -83.15%
Earnings Growth (1Y) -98.99% Earnings Growth (3Y) N/A
Revenue Growth (5Y) -38.61% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 71,000.0 Net Income (TTM) 401,000.0
ROE 1.14% ROA 0.98%
Gross Margin N/A Operating Margin -30712.68%
Net Margin 564.79% Free Cash Flow (TTM) -5.24 M
ROIC -56.48% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.40
Interest Coverage -1038.38 Asset Turnover 0.00
Working Capital -6.27 M Tangible Book Value 32.52 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 153.47 Forward P/E N/A
P/B Ratio 1.89 P/S Ratio 866.80
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8.51%
Market Cap 61.54 M Enterprise Value 61.54 M
Per Share
EPS (Diluted TTM) -5.63 Revenue / Share 0.01
FCF / Share -0.83 OCF / Share -0.82
EPS CAGR (1Y) -1226.00% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 43.66% FCF Conversion -1305.99%
SBC-Adj. FCF -8.64 M Growth Momentum -59.02

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 71,000.0 3.00 M 2.50 M 377,000.0 500,000.0
Net Income 401,000.0 39.79 M -64.18 M -88.98 M -50.35 M
EPS (Diluted) -5.63 0.50 -9.16 — —
Gross Profit — — — — -85,000.0
Operating Income -21.81 M -44.49 M -68.80 M -90.93 M -54.39 M
EBITDA — — — — —
R&D Expenses 4.49 M 5.93 M 14.28 M 25.55 M 19.85 M
SG&A Expenses — — — — —
D&A 105,000.0 1.20 M 2.93 M 2.46 M —
Interest Expense 21,000.0 45,000.0 589,000.0 1.27 M 53,000.0
Income Tax 0.0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 38.81 M 30.66 M 33.12 M 53.98 M 86.98 M
Total Liabilities 16.51 M 37.69 M 57.14 M 43.05 M 7.56 M
Shareholders' Equity 33.97 M -2.50 M -53.83 M -9.68 M 61.67 M
Total Debt — — — — —
Cash & Equivalents 1.54 M 1.19 M 19.64 M 39.74 M 77.26 M
Current Assets 2.56 M 2.16 M 24.50 M 43.93 M 82.64 M
Current Liabilities 14.84 M 35.45 M 54.18 M 41.20 M —